Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F β-amyloid precursor protein

Neuroscience Letters

Volumn 277, Issue 1, 1999, Pages 49-52

  Dodart, Jean Cosme ^a   Mathis, Chantal ^a   Bales, Kelly R ^b   Paul, Steven M ^b   Ungerer, Arielle ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Brain glucose metabolism; Transgenic mice; 14C 2 deoxyglucose; Amyloid precursor protein

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032735889     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00847-2     Document Type: Article

References (23)

1. Berent S., Giordani B., Foster N., Minoshima S., Lajiness-O'Neill R., Koeppe R., Kuhl D.E. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J. Psychiatr. Res. 33:1999;7-16.
2. Bontempi B., Jaffard R., Destrade C. Differential temporal evolution of post-training changes in regional brain glucose metabolism induced by repeated spatial discrimination training in mice: visualization of the memory consolidation process? Eur. J. Neurosci. 8:1996;2348-2360.
3. Cassel J.C., Cassel S., Galani R., Kelche C., Will B., Jarrard L. Fimbria-fornix vs selective hippocampal lesions in rats: effects on locomotor activity and spatial learning and memory. Neurobiol. Learn. Mem. 69:1998;22-45.
4. Cho Y.H., Kesner R.P. Involvement of entorhinal cortex or parietal cortex in long-term spatial discrimination memory in rats: retrograde amnesia. Behav. Neurosci. 110:1996;436-442.
5. DeCoteau W.E., Kesner R.P. Effects of hippocampal and parietal cortex lesions on the processing of multiple-object scenes. Behav. Neurosci. 112:1998;68-82.
6. Desgranges B., Baron J.C., de la Sayette V., Petit-Taboué M.-C., Benali K., Landeau B., Lechevalier B., Eustache F. The neural substrate of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain. 121:1998;611-631.
7. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., Ungerer A. Memory and learning impairment precede amyloid deposition in the V717F PDAPP transgenic mouse. Soc. Neurosci. Abstr. 23:1997;1637.
8. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F β-amyloid precursor protein. Behav. Neurosci. 113:1999;1-9.
9. Ennaceur A. Effects of lesions of the Substantia Innominata/Ventral Pallidum, globus pallidus and medial septum on rat's performance in object-recognition and radial-maze tasks: physostigmine and amphetamine treatments. Pharmacol. Res. 38:1998;251-263.
10. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
11. Hunt P., Aggleton J.P. An examination of the spatial working memory deficit following neurotoxic medial dorsal thalamic lesions in rats. Behav. Brain Res. 97:1998;129-141.
12. Ibanez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M.B., Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology. 50:1998;1585-1593.
13. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
14. 42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;1550-1555.
15. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997;273-284.
16. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17:1997;1046-1054.
17. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;4811-5795.
18. Nordberg A. Clinical studies in Alzheimer patients with positron emission tomography. Behav. Brain Res. 57:1993;215-224.
19. Parpura-Gill A., Beitz D., Uemura E. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain. Res. 754:1997;65-71.
20. Rockenstein E.M., McConlogue L., Tan H., Power M., Masliah E., Mucke L. Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 270:1995;28257-28267.
21. Shen J., Barnes C.A., Wenk G.L., McNaughton B.L. Differential effects of selective immunotoxic lesions of medial septal cholinergic cells on spatial working and reference memory. Behav. Neurosci. 110:1996;1181-1186.
22. 14C]2-deoxyglucose uptake in subcortical and cortical structures during memory consolidation of an operant training in mice. Behav. Neural. Biol. 56:1991;43-61.
23. Yasuno F., Imamura T., Hirono N., Ishii K., Sasaki M., Ikejiri Y., Hashimoto M., Shimomura T., Yamashita H., Mori E. Age at onset and regional cerebral glucose metabolism in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 9:1998;3-67.